HM
CLVS
HealthCor Management’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,491,376
| Closed | -$5.86M | – | 66 |
|
|
2019
Q3 | $5.86M | Sell |
1,491,376
-156,714
| -10% | -$616K | 0.22% | 45 |
|
|
2019
Q2 | $24.5M | Buy |
1,648,090
+249,790
| +18% | +$3.71M | 0.95% | 35 |
|
|
2019
Q1 | $34.7M | Buy |
+1,398,300
| New | +$34.7M | 1.4% | 28 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 46 |
|
|
2018
Q1 | – | Sell |
-973,840
| Closed | -$66.2M | – | 52 |
|
|
2017
Q4 | $66.2M | Buy |
973,840
+326,420
| +50% | +$22.2M | 2.16% | 23 |
|
|
2017
Q3 | $53.3M | Buy |
647,420
+401,120
| +163% | +$33.1M | 1.79% | 20 |
|
|
2017
Q2 | $23.1M | Sell |
246,300
-53,700
| -18% | -$5.03M | 0.83% | 28 |
|
|
2017
Q1 | $19.1M | Sell |
300,000
-325,000
| -52% | -$20.7M | 0.88% | 27 |
|
|
2016
Q4 | $27.8M | Sell |
625,000
-75,000
| -11% | -$3.33M | 1.57% | 21 |
|
|
2016
Q3 | $25.2M | Sell |
700,000
-1,950,000
| -74% | -$70.3M | 1.54% | 22 |
|
|
2016
Q2 | $36.4M | Buy |
2,650,000
+650,000
| +33% | +$8.92M | 1.98% | 16 |
|
|
2016
Q1 | $38.4M | Buy |
2,000,000
+475,000
| +31% | +$9.12M | 2.18% | 16 |
|
|
2015
Q4 | $53.4M | Buy |
+1,525,000
| New | +$53.4M | 3.24% | 13 |
|
|
2014
Q2 | – | Sell |
-475,000
| Closed | -$32.9M | – | 65 |
|
|
2014
Q1 | $32.9M | Buy |
475,000
+376,437
| +382% | +$26.1M | 1.98% | 18 |
|
|
2013
Q4 | $5.94M | Sell |
98,563
-157,458
| -62% | -$9.49M | 0.36% | 37 |
|
|
2013
Q3 | $15.6M | Buy |
256,021
+131,021
| +105% | +$7.97M | 0.83% | 33 |
|
|
2013
Q2 | $8.37M | Buy |
+125,000
| New | +$8.37M | 0.51% | 39 |
|